Evidence map›Paper›PMID 30984975›Full record

ArticleJournal of medical entomology2019

Ability of Two Commercially Available Host-Targeted Technologies to Reduce Abundance of Ixodes scapularis (Acari: Ixodidae) in a Residential Landscape.

Robert A Jordan, Terry L Schulze

Abstract readEvaluation Study
In one paragraph

Article in Journal of medical entomology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Why are the ticks winning, and what can we do about it?Ticks and tick-borne diseases · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Efficacy of a federally approved flea bait, orally administered to white-footed mice (International journal for parasitology. Parasites and wildlife · 2023
    Article
  12. Does Experimental Reduction of Blacklegged Tick (Pathogens (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robert A JordanMonmouth County Mosquito Control Division, Tinton Falls, NJ.
Terry L SchulzeTerry L. Schulze, Ph.D., Inc., Perrineville, NJ.

Funding

Intramural CDC HHS CC999999Intramural CDC HHS HHSD2002013M54270P
6 · The paper itself

Abstract

Host-targeted technologies provide an alternative to the use of conventional pesticide applications to reduce the abundance of Ixodes scapularis Say, the vector for an array of tick-associated human diseases. We compared the ability of Damminx Tick Tubes (Damminix) and SELECT Tick Control System (Select TCS) bait boxes to control host-seeking I. scapularis nymphs in a wooded residential environment. Small mammals accepted and used Select TCS bait boxes with greater frequency compared to Damminix tubes over the course of the 2-yr trial. Nymphal tick infestation prevalence and intensity on captured mice and chipmunks provided no conclusive evidence of a treatment effect during May-June of both years. However, both treatments had a measurable effect on larval tick burdens in July-August and the magnitude of the effect was greater at the Select TCS-treated area and reflected the fact that Select TCS effectively treated chipmunks, while Damminix did not. Deployment of Damminix resulted in 27.6 and 20.3% control of questing nymphs in treated areas at 1 yr and 2 yr postintervention, while Select TCS bait boxes provided 84.0 and 79.1% control, respectively. The economics of residential tick control using these products in wooded residential landscapes is discussed.

Indexed as

IxodesAnimalsMiceNymphPeromyscusSciuridaeTick ControlDamminix Tick TubesIxodes scapularisSELECT TCS

Identifiers

PMID30984975
PMCPMC8116133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.